The partners will use UCSF’s patient data to make Proscia’s AI technology more applicable to a broader range of patients and medical techniques, including variations in biopsy and tissue preparation methods, tissue staining procedures, digital scanning processes and diagnoses, according to a March 2 news release.
Though the partnership will initially center on improving prostate cancer diagnoses, UCSF and Proscia will eventually expand their focus to improve other pathology processes with deep learning AI.
More articles on AI:
There’s not enough data to train AI symptom checkers for coronavirus: WSJ report
AMA developing EHR-connected AI tools to reduce physician burnout
Cleveland Clinic’s AI center spearheads 20 research projects
